Vabysmo Injection for Retinal Fluid in Egypt
Vabysmo Injection: A Breakthrough in Retinal Fluid Treatment and Its Price in Egypt
Do you suffer from recurrent retinal fluid and are tired of monthly injections? Vabysmo injection (faricimab) may be the solution to reduce the frequency of injections.
Injections of anti-vascular endothelial growth factor (Anti-VEGF) agents are considered among the most important modern treatment methods for many eye diseases.
These agents are primarily used in:
● Treatment of macular edema in diabetic retinopathy.
● Treatment of macular edema resulting from venous occlusion.
● Treatment of age-related wet macular degeneration.
● Treatment of neovascular glaucoma.
● Choroidal neovascularization associated with myopia and some other diseases.
They are also used in some cases of vitreous hemorrhage.
And it is preferred to inject them as a preparatory procedure for tractional retinal detachment surgeries.
There are well-known types of Anti-VEGF agents in global markets,
and companies and research institutions compete to offer new agents capable of controlling the disease in the shortest possible time, with fewer complications, and with the fewest number of injections.
Learn about the most common causes of macular edema.
Faricimab injection, known in Egypt as Vabysmo, is one of the latest and most powerful active agents currently used,
offering faster resolution of fluid
and reducing the need for frequent injections.
It has shown good success rates in reducing the number of injections for wet macular degeneration to 3 injections per year,
while aflibercept (Eylea) recorded its lowest rate at 4 injections per year.
Learn about the role of ANTI-VEGF injections in treating diabetic retinopathy.
Dr. Mahmoud Hassan's Opinion on Vabysmo Injection:
Vabysmo (faricimab) injection is the newest type of injection currently available, with the highest concentration and lowest complication rate. It works through multiple mechanisms to achieve faster drying of macular fluid compared to Eylea injection, as proven by studies and practical experience. While the progress in the efficacy of ANTI-VEGF injections is slow and cautious, it is effective in many cases in ending the suffering of some patients more quickly, with relatively lower financial burdens and fewer risks.
https://youtube.com/shorts/kKu6wW9h-W0?si=WHcGxDZ-sMCd5Mxl
Faricimab (Vabysmo) injection is available at Al-Mashreq Eye Center.. The Retina Clinic | Dr. Mahmoud Hassan offers various solutions, and a treatment plan is developed for complex retinal diseases and those unresponsive to injections.
What is the cost of a Vabysmo eye injection?
Frequently Asked Questions about Vabysmo Injection
1. What distinguishes Vabysmo injection from Eylea or Lucentis injections?
Vabysmo is unique as the first injection to use "dual antibody" technology. It not only blocks the (VEGF) protein responsible for fluid leakage but also targets the (Ang-2) protein, which causes blood vessel weakening and inflammation. This leads to longer retinal stability and extended intervals between injections, reaching up to 4 months in many cases.
The following table illustrates the difference between Vabysmo's advanced technology and other currently available injection types:
<table border="1" style="width:100%; border-collapse: collapse; text-align: right; direction: rtl;">
<tr style="background-color: #004a99; color: white;">
<th style="padding: 10px;">Comparison Point</th>
<th style="padding: 10px;">Vabysmo Injection</th>
<th style="padding: 10px;">Traditional Injection (Eylea)</th>
</tr>
<tr>
<td style="padding: 10px; font-weight: bold;">Mechanism of Action</td>
<td style="padding: 10px;">Targets two proteins (VEGF & Ang-2)</td>
<td style="padding: 10px;">Targets one protein (VEGF)</td>
</tr>
<tr style="background-color: #f2f2f2;">
<td style="padding: 10px; font-weight: bold;">Duration of Efficacy</td>
<td style="padding: 10px;">Up to 4 months</td>
<td style="padding: 10px;">1 to 2 months</td>
</tr>
<tr>
<td style="padding: 10px; font-weight: bold;">Injection Frequency</td>
<td style="padding: 10px;">Less frequent</td>
<td style="padding: 10px;">More frequent</td>
</tr>
</table>
2. How many Vabysmo injections do I need?
The number varies depending on the macula's fluid status and the eye's response. Typically, we start with 4 monthly doses (loading phase), then the condition is evaluated to gradually increase the interval between injections, which reduces the burden on the patient compared to traditional injections.
3. Is Vabysmo Injection Painful? And Does It Have Side Effects?
The injection procedure is performed under complete sterilization and local anesthetic drops, lasting only a few seconds with minimal pain. Side effects are very rare and may include slight redness or the temporary appearance of floaters that disappear within a few days.
4. When Does Vabysmo Injection Start Improving Vision?
The biological effect of reducing fluid leakage begins within the first few days after the injection. Patients typically notice a gradual improvement in vision clarity and a reduction in blurriness within two weeks to one month of the first dose. Improvement continues with adherence to the treatment plan.
Book a consultation appointment to evaluate the suitability of Vabysmo injection for your condition.